Evidence map›Paper›PMID 36045134›Full record

ArticleNPJ Regenerative medicine2022

A STAT5-Smad3 dyad regulates adipogenic plasticity of visceral adipose mesenchymal stromal cells during chronic inflammation.

Rahul Das, Jayeeta Giri, Pradyut K Paul, Nicole Froelich, Raghavan Chinnadurai, Sara McCoy, Wade Bushman, Jacques Galipeau

Open access · goldAbstract read
In one paragraph

Article in NPJ Regenerative medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Activin Actions in Adipocytes.The Journal of clinical endocrinology and metabolism · 2025
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Rahul DasDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Jayeeta Giri *Department of Medicine, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Pradyut K Paul *Department of Medicine, University of Wisconsin-Madison, Madison, WI, 53705, USA.ORCID http://orcid.org/0000-0002-9922-4877
Nicole FroelichDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Raghavan ChinnaduraiDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Sara McCoyDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, 53705, USA.ORCID http://orcid.org/0000-0002-5293-4185
Wade BushmanDepartment of Urology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, 53705, USA.
Jacques GalipeauDepartment of Medicine, University of Wisconsin-Madison, Madison, WI, 53705, USA. jgalipeau@wisc.edu.ORCID http://orcid.org/0000-0002-9374-1996
University of Wisconsin–Madison · US

Funding

Cytokine primed autologous Mesenchymal Stromal Cells for therapy of colitis.R01DK109508 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI GALIPEAU, JACQUES · 2016 to 2019
$2.1M
American Heart Association (American Heart Association, Inc.) 17POST33670196NIDDK NIH HHS R01 DK109508U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) R01DK109508
6 · The paper itself

Abstract

Adipogenic differentiation of visceral adipose tissue-resident multipotent mesenchymal stromal cells (VA-MSC) into adipocytes is metabolically protective. Under chronic inflammatory stress, this neoadipogenesis process is suppressed by various pro-inflammatory cytokines and growth factors. However, the underlying mechanism(s) regulating VA-MSC plasticity remains largely unexplored. Using an adipogenic differentiation screen, we identified IFNγ and TGFβ as key inhibitors of primary human VA-MSC differentiation. Further studies using human and mouse VA-MSCs and a chronic high-fat diet-fed murine model revealed that IFNγ/JAK2-activated STAT5 transcription factor is a central regulator of VA-MSC differentiation under chronic inflammatory conditions. Furthermore, our results indicate that under such conditions, IFNγ-activated STAT5 and TGFβ-activated Smad3 physically interact via Smad4. This STAT5-Smad4-Smad3 complex plays a crucial role in preventing the early adipogenic commitment of VA-MSCs by suppressing key pro-adipogenic transcription factors, including CEBPδ, CEBPα, and PPARγ. Genetic or pharmacological disruption of IFNγ-TGFβ synergy by inhibiting either STAT5 or Smad3 rescued adipogenesis under chronic inflammatory stress. Overall, our study delineates a central mechanism of MSC plasticity regulation by the convergence of multiple inflammatory signaling pathways.

Identifiers

PMID36045134
PMCPMC9433418
OpenAlexW4293740556

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.